AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05336526 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ESTYME® MATRIX Round Microtextured Silicone Gel-Filled Breast Implants
Description: Bilateral brest augmentation in primary intention
Study NCT04784494 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Theapy (MagPro XP MST)
Description: MST treatment will be administered over the frontal/vertex cortex using 100 Hz stimulation using the MagPro XP MST with Cool TwinCoil. The MST determination of seizure threshold will be done using 100% machine output applied at 100 Hz at progressively escalating train durations, commencing at 2 seconds and increasing by 2 seconds with each subsequent stimulation until an adequate seizure is produced. During subsequent sessions, one stimulation will be delivered using a train duration that is 4 seconds longer than the train duration at threshold (with a maximum train duration of 10 seconds).~MST treatments will be administered twice a week, for up to 16 treatments. This will be performed under the effect of anesthesia. The treatment procedure is approximately 10 minutes, followed by a recovery period of approximately 30 minutes.
Study NCT03914482 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: MRI
Description: The device will acquire thermoacoustic data while the ultrasound probe acquires ultrasound images, and an MR of the liver is acquired as a comparative modality
Study NCT05878093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: solution for subcutaneous injection
Study NCT05878093 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: solution for subcutaneous injection
Study NCT05878093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide
Description: nasal spray (suspension)
Study NCT05878093 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Budesonide
Description: nasal spray (suspension)
Study NCT06603844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CRB-601 monoclonal antibody
Description: CRB-601
Study NCT06603844 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 monoclonal antibody
Description: Anti-PD(L)-1 used as per label
Study NCT06603844 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Immune-priming single lesion SBRT
Description: single-lesion immune-priming SBRt
Study NCT06691100 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: 30-minute exercise bout in a cycle ergometer at 60 to 70% of the Heart Rate Reserve (HRR) and corresponding power (watts).
Study NCT06689059 — intervention group
Intervention type: OTHER
Intervention: Multimodal Data Integration and Multi-Task Learning
Description: This study utilizes a multimodal data integration and multi-task learning approach to predict perioperative events after hip replacement surgery. By combining various data types, including demographics, surgical details, medical history, and lab results, the model enhances prediction accuracy for outcomes like AKI, blood transfusion needs, and ICU transfers. The use of ensemble learning algorithms such as CatBoost optimizes the platform's performance, offering a unique method for clinical decision support.
Study NCT06693063 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Some data will be collected for all patients included: medical and family history, chest pain data and medical care data
Study NCT06693466 — intervention group
Intervention type: OTHER
Intervention: Facial expression block
Description: Data will be collected to assess the facial expression, body movements and vocalization of (non-) painful heat stimuli. The experiment includes individually tailored and randomly administered painful (perceived as moderate pain) and non-painful heat stimuli.
Study NCT06693466 — intervention group
Intervention type: OTHER
Intervention: Conditioned pain modulation block
Description: The conditioned pain modulation will be tested according to internationally agreed standards and includes a painful phasic heat (test stimulus) and a painful tonic cold stimulus (conditioning stimulus).
Study NCT06693466 — intervention group
Intervention type: OTHER
Intervention: Pain facilitation block
Description: Pain facilitation will be assessed by using painful mechanical pinprick stimuli. The magnitude of pain experienced after a single mechanical pinprick stimulus is compared to that of a train of 10 pinprick stimuli of the same force.
Study NCT06691698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Cognitive Orientation to Daily Occupational Performance Approach
Description: CO-OP is a client-centred, performance-based, problem-solving focused, occupation-focused and occupation-based intervention. In CO-OP the person is guided to use a meta-cognitive strategy to find his or her own strategies for specific activities. The main purpose is to enable meta-cognitive thinking in every day activities, leading to enhanced self-efficacy, occupational performance and independency.
Study NCT04647864 — intervention group
Intervention type: DEVICE
Intervention: Transcatheter Aortic Valve Implantation
Description: Replacement of the aortic valve of the heart through the blood vessels, delivered via one of several access methods.
Study NCT04768777 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)
Description: The current behavioral intervention consists of two primary components; an internet website and one-on-one video chats with a behavioral coach. The internet website involves content delivered through interactive video courses.The interactive video courses are based on elements of social cognitive theory. Each course consists of an introduction, the primary content, and a take home message.The interactive courses include embedded, supplementary options such as videos on content and worksheets related to the topic.A pedometer is provided for tracking steps, and these steps will be entered into the website so progress can be monitored. The chats support adherence to the intervention,discussion of website material,supportive accountability,and reporting of adverse events/injuries. The chats are conducted face-to-face through an online videoconferencing platform. There are a total of 12 chats over 16 weeks. Chats occur on weeks 1-8, 10-11, 13 and16.
Study NCT06719011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0174-1213 A
Description: Participants will be randomized to receive NNC0174-1213 A administered as subcutaneous (s.c. under the skin) injection.~Single ascending dose (SAD) will be injected for Part A cohorts and multiple ascending doses (MAD) will be injected for Part B cohorts.
Study NCT06719011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cagrilintide B
Description: Participants will be randomized to receive Cagrilintide B administered as subcutaneous (s.c. under the skin) injection.~Single ascending dose (SAD) will be injected for Part A cohorts and multiple ascending doses (MAD) will be injected for Part B cohorts.
Study NCT06338631 — intervention group
Intervention type: OTHER
Intervention: Diet
Description: Pesonalized diet plan, devoloped according to Guidelines for dietary treatment of obesity, to be followed for a duration of 12 months
Study NCT06719011 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo A (NNC0174 1213 A)
Description: Participants will be randomized to receive Placebo administered as subcutaneous (s.c. under the skin) injection.~Single ascending dose (SAD) will be injected for Part A cohorts and multiple ascending doses (MAD) will be injected for Part B cohorts.
Study NCT06718244 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: single dose of Inaticabtagene autoleucel
Description: Inaticabtagene autoleucel will be transfusioned intravenously at the recommended dose of 0.5×10\^8 (ranging 0.2-0.6×10\^8) viable CAR-T cells.
Study NCT06746714 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Proactive population care (active application of HOAP principles in patients flagged as high risk for hypoglycemia)
Description: The Hypoglycemia Champion (HC) pharmacist reviewed patient charts before conducting proactive outreach. They did not contact subjects with active psychiatric issues or those admitted to a skilled nursing facility. The patient's care team (PCP and APM) were also contacted for peer consent. The outreach process involved an initial phone call with a secure electronic message or mailed letter (for those without secure KPNC patient portal access) if the initial call was unsuccessful. A second and third phone call attempt was made for non-responders.
Study NCT06746714 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care, after system-side dissemination of HOAP
Description: Patients had their diabetes treated as usual by their diabetes care provider or primary care physician, after system-wide dissemination of HOAP.
Study NCT06746818 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Heart Math interventions
Description: . The key components of Heart Math interventions include:~1. Heart Rate Variability (HRV) Training: This involves biofeedback techniques to help individuals learn how to control their heart rate and promote emotional balance.~2. Quick Coherence Technique: Participants are guided through a series of steps to shift their emotional state from stress to calmness, facilitating a sense of peace and emotional clarity.~3. Focus on Positive Emotions: Encouraging individuals to cultivate feelings like gratitude and compassion can enhance resilience and overall mental well-being.~4. Mindfulness Practices: Incorporating mindfulness helps individuals become more aware of their thoughts and feelings, allowing them to respond to stressors more effectively.
Study NCT06747806 — intervention group
Intervention type: PROCEDURE
Intervention: Cardiac Surgery and Procedures
Description: To assess blood and tissue biomarkers of patients undergoing cardiac surgery
Study NCT06742047 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Professional development programme
Description: The professional development programme include dialogue groups facilitated by registered nurses (RN) who are expert and experienced supervisors that received a three day training before conducting the groups. Then including education days with joint lectures and simulations with experts in the field with experience. The programme provides NGNs with regular opportunities for reflection for learning from experiences of care to enhance personal and professional growth.
Study NCT06746025 — intervention group
Intervention type: BEHAVIORAL
Intervention: Quit Center cessation program
Description: Lifestyle modifications based on the Quit Center cessation program.
Study NCT05945225 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sonicare DiamondClean 9000 Philips®
Description: Brush teeth with the electric toothbrush daily during 3 months
Study NCT05945225 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HydroSonic Easy Curaden®
Description: Brush teeth with the hydrosonic toothbrush daily during 3 months
Study NCT05945225 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Manual toothbrush Oral-B 123
Description: Brush teeth with the manual toothbrush daily during 3 months
Study NCT05945225 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Manual toothbrush Curaprox CS 5460
Description: Brush teeth with the manual toothbrush daily during 3 months
Study NCT06501196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BH-30236
Description: BH-30236 will be provided as either a 5 or 30 mg tablet. Patients will take BH-30236 orally depending on their dose level assignment.
Study NCT05634343 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: experimental group 1
Description: Laughter therapy, also called therapeutic laughter, is used to relieve pain and stress and to promote a general sense of well-being. Laughter therapy is simply a method of 'laughing for no reason' in which the person interacts in a group setting with improvisation or pantomime-like exercises and childish games without humour, jokes or funny events. The aim is thus to benefit from laughter.
Study NCT05634343 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: experimantal group 2
Description: Mindfulness is purposefully drawing attention in the desired direction so that we can stay in the present moment without judgment. It is also defined as a conscious understanding of what is happening in the moment we live in with an open and loving attitude. According to another definition, mindfulness includes paying attention to what is happening in the present moment, noticing the quality of this attention, and accepting what is noticed without judgment. With conscious awareness, the individual discovers how to live in harmony with all the events that take place in the present moment, place and time, without any evaluation, rather than the sorrows and regrets of the past, the anxieties and worries of the future. Mindfulness helps us to relate to our experiences by enabling us to see the positive-negative, good-bad experiences we have had objectively.
Study NCT05991453 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anesthetic technique Propofol TIVA
Description: Propofol TIVA no inhaled agent
Study NCT05991453 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Anesthetic technique inhaled agent
Description: Must administer inhaled agent.
Study NCT05838287 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pioglitazone
Description: Participants will be taking Pioglitazone tablets 1/day for 24 weeks.
Study NCT05838287 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for Pioglitazone
Study NCT06631508 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Preoperative Period, Postoperative Period, 2th week after discharge, 6th week after discharge, 10th week after discharge, 14th week after discharge
Description: Showing training videos to patients before and after pelvic organ prolapse surgery and following up after discharge
Study NCT05727501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Post isometric relaxation
Description: post isometric relaxation in which 3-5 repetitions for 7-10 seconds hold in each session for three sessions per week in alternate days for four weeks.
Study NCT05727501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Post facilitation stretching
Description: post facilitation stretching in which 3-5 repetitions for 7-10 seconds hold in each session for three sessions per week in alternate days for four weeks.
Study NCT06631248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coordinative exercise protocol
Description: During the eight-week period, all children in the structured coordinative exercise intervention group participated in 30-minute sessions twice a week on the same day and time. The purpose-oriented basic movement patterns created in the coordinative exercise content were organised in a play-oriented manner suitable for the preschool age range.
Study NCT06630988 — intervention group
Intervention type: OTHER
Intervention: Failure rates
Description: Describe the management failure rate for hand infections, including panariasis, phlegmons and arthritis.
Study NCT06630715 — intervention group
Intervention type: DRUG
Intervention: Upadacitinib 15 MG [Rinvoq]
Description: 15 mg/ day
Study NCT05252247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immobilisation
Description: Eight hours prior to attending the immobilisation session, a splint will be fitted to the hand of the participant and remain until the session start.
Study NCT05252247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Eight hours prior to attending the exercise session, the participant will be instructed to perform 150 ballistic finger movements every hour until the session start.
Study NCT04552912 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Build Stamina Program
Description: Build StaMINA intervention is a self-management intervention that provides information, motivation, behavioral skills to engage in PA, and ultimately a tailored PA program for adults with AL who are receiving consolidation/maintenance chemotherapy.
Study NCT05178914 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Treatment adaptation
Description: Patients will benefit from intensified treatment or de escalation treatment according to the result of the index of microcirculatory resistance
Study NCT05178914 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Treatment adaptation
Description: Patients will benefit from intensified treatment or de escalation treatment according to the result of the index of microcirculatory resistance
Study NCT04526899 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT111
Description: IV injection
Study NCT04526899 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: IV infusion
Study NCT06630754 — intervention group
Intervention type: OTHER
Intervention: No Intervention: Observational Cohort
Description: No intervention; observation cohort study
Study NCT06629935 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: orthognathic surgery
Description: Le Fort I surgery
Study NCT06629935 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: orthognathic surgery
Description: Le Fort I surgery
Study NCT06402487 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Propionic acid 1000 mg capsule
Description: Patients will be assigned to propionic acid or placebo as add on MS treatment.
Study NCT06631313 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PureWick System
Description: The PureWick System consists of the PureWick Urine Collection System used with either the PureWick Male External Catheter or the PureWick Flex Female External Catheter, which are intended for non-invasive urine output management.
Study NCT06402487 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will be assigned to propionic acid or placebo as add on MS treatment.
Study NCT06631742 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exergaming on Dividat Senso
Description: The active dance video game is played with the Dividat Senso (Dividat \| Senso: cognitive-motor training). It consists of a dance disc with four arrows (up, down, left, right), and the game is played on a large screen (which is connected to the PC). The screen indicates which arrow the person should step on, thus controlling the game through body movements. The games give the person feedback in the form of auditory, visual, and somatosensory stimuli.
Study NCT06631742 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Standardised care with meal service, individual activities (e.g. hiking group, walking group, exercise group, handicrafts, gardening group, singing, painting or lunch) and customized care and support as required.
Study NCT06569524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQA2225/AP025 or TQA2225/AP025 Placebo 25mg
Description: To evaluate the efficacy and safety of TQA2225/AP025 (25mg) in patients with Non-Alcoholic Steatohepatitis (NASH)
Study NCT06569524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQA2225/AP025 or TQA2225/AP025 Placebo 50mg
Description: To evaluate the efficacy and safety of TQA2225/AP025 (50mg) in patients with Non-Alcoholic Steatohepatitis (NASH)
Study NCT06094296 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986315
Description: Specified dose on specified days
Study NCT06094296 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Specified dose on specified days
Study NCT06250816 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The hospital gown with cartoon characters
Description: The patient will be asked to choose one of the hospital gowns with cartoon characters they want to wear and put it on with parental assistance.
Study NCT06094296 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nivolumab
Description: Specified dose on specified days
Study NCT06094296 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Specified dose on specified days
Study NCT06094296 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Specified dose on specified days
Study NCT06094296 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Specified dose on specified days
Study NCT04862429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Contrast enhanced mammography guided biopsy (diagnostic procedure)
Description: With visible contrast-enhancement, stereotactic biopsy will be performed under CESM guidance. After administration of an additional dose of iodized contrast-enhancement (Omnipaque), the insertion of the biopsy needle and the biopsy sampling will be targeted on the area of greatest enhancement in the context of calcifications. In the absence of contrast-enhancement, stereotactic biopsy Mammotome will be performed, using X-ray guidance. The insertion of the biopsy needle and biopsy will be targeted on the most suspicious calcification cluster or area. At the end of the procedure, a metal clip marker will be placed in the biopsy site; the placement will be verified with dual orthogonal mammography projection (as regular clinical practice).
Study NCT04862429 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mammography guided biopsy (diagnostic procedure)
Description: For all lesions, stereotactic biopsy Mammotome will be performed, using X-ray guidance. The insertion of the biopsy needle and biopsy will be targeted on the most suspicious calcification cluster or area.~At the end of the procedure, a metal clip marker will be placed in the biopsy site; the placement will be verified with dual orthogonal mammography projection (as regular clinical practice).